Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE

Ann Rheum Dis. 2015 Apr;74(4):791-2. doi: 10.1136/annrheumdis-2014-206506. Epub 2015 Jan 21.
No abstract available

Keywords: Cytokines; Systemic Lupus Erythematosus; T Cells; Treatment.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Interleukin-2 / therapeutic use*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Remission Induction
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Interleukin-2